41
total announcements
GUJTHEM.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹4,668 Cr
P/E (TTM)
80.2
EPS (TTM)
₹4.47
52W Low
₹225.05
52W High
₹479.00
Dividend Yield
0.18%
Beta
0.64
Price / Book
13.6
Debt / Equity
56.2
Revenue (TTM)
₹174 Cr
Gross Margin
66.94%
Operating Margin
38.41%
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has announced an amendment to its Articles of Association, specifically deleting a clause related to share price determination by a registered valuer. The change allows for the sale of shares to any person, either for cash or other consideration. The amendment was approved by the company's shareholders at an Extraordinary General Meeting on August 22, 2026.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has announced the outcome of a postal ballot, where shareholders voted on three special resolutions. The resolutions include raising funds by issuing equity shares through a qualified institutions placement, amending the articles of association, and private placement of non-convertible debentures and/or debt securities. All three resolutions were passed with requisite majority.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has announced the voting results and scrutinizer's report on postal ballot through e-voting for passing of special resolutions. The resolutions include raising funds by issue of equity shares through qualified institutions placement, amendment to the articles of association, and private placement of NCDs and/or debt securities. The resolutions were passed with requisite majority.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd held an Extra-ordinary General Meeting (EGM) on August 22, 2026, where shareholders approved several resolutions, including the approval of Material Related Party Transactions with Promoter/Promoter group entities, amendment to the Articles of Association, and private placement of NCDs and/or debt securities.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd held an EGM on 22nd August 2026, where 56 members were present. The meeting approved three resolutions: approval of material related party transactions, amendment to the articles of association, and private placement of NCDs and/or debt securities. The resolutions were passed with the requisite majority.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd submitted call recordings of the investor/analyst conference call held on August 10, 2026, as per Regulation 30 and Regulation 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has announced the publication of un-audited financial results for the quarter ended 30.06.2026, as per Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has released its Q1 FY2026-27 investor presentation, showing a 22.1% year-on-year growth in top line to Rs. 43.8 crores, with EBITDA increasing 49.4% to Rs. 20.8 crores and PAT improving 22.1% to Rs. 11.1 crores. The company has also made significant strides in its inorganic expansion initiatives, including the acquisition of Sanofi's brands and MicroBiopharm in Japan.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with a net profit of ₹1,106.67 lakhs and earnings per share of ₹1.02.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has announced its unaudited standalone financial results for the quarter ended June 30, 2026, with a net profit of ₹1,106.67 lakhs and earnings per share of ₹1.02.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has received a disclosure under Regulation 10(6) of SEBI (SAST) Regulations, 2011, regarding an inter-se transfer of shares among promoters and promoter group members, with Sachin D. Patel acquiring 5,23,560 equity shares from Pharmaceutical Business Group India Limited at Rs. 382 per share.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has scheduled a conference call to discuss its 1QFY27 financial performance on August 10, 2026.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd publishes Notice of Extra-Ordinary General Meeting (EGM) in newspapers as per SEBI Listing Regulations.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has called an Extra-Ordinary General Meeting (EGM) on August 22, 2026, to consider approval of material related party transactions with promoter/promoter group entities and amendment to the Articles of Association.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has scheduled a Board meeting on 07/08/2026 to consider and approve the Un-Audited Financial Results for the quarter ended on 30th June, 2026 and Limited Review Reports of the Auditor thereon.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has published a notice of postal ballot in a newspaper as per SEBI regulations.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has announced a Notice of Postal Ballot for approval of a resolution through remote e-voting. The resolution is proposed for approval of the Members of the Company by way of Postal Ballot through remote e-voting only. The notice is being sent only through electronic mode to those Members whose e-mail addresses are registered with the Company/Depository Participants.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has received a revised disclosure from Pharmaceutical Business Group (India) Ltd regarding the creation of an indirect encumbrance over 5,12,40,000 shares of the company held by PBGIL, a promoter group entity, due to a pledge of 25,24,245 shares and a non-disposal undertaking of 21,57,855 shares by Vividhmargi Investments Private Ltd in favor of CTL Trusteeship Ltd.
Gujarat Themis Biosyn Ltd
Gujarat Themis Biosyn Ltd has received a revised disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, regarding the creation of an indirect encumbrance over 5,12,40,000 shares of the company held by Pharmaceutical Business Group (India) Limited, a promoter group entity, due to a pledge of 25,24,245 shares of PBGIL by Vividhmargi Investments Private Limited in favour of CTL Trusteeship Limited.
Gujarat Themis Biosyn Ltd
Themis Medicare Ltd has released 16,50,000 shares of Gujarat Themis Biosyn Ltd from pledge, as per SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.